AstraZeneca Gets New U.S. Approval for Seroquel XR

AstraZeneca announced that the U.S. Food and Drug Administration (FDA) has approved once-daily SEROQUEL XR (quetiapine fumarate) Extended-Release Tablets for maintenance treatment of schizophrenia in adult patients.
BioSpace